Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway
Open Access
- 31 December 2020
- journal article
- research article
- Published by Wiley in PPAR Research
- Vol. 2020, 1-13
Abstract
Liver fibrosis is a pathological process involving diffuse extracellular matrix (ECM) deposition in the liver. It is typical of many chronic liver diseases, including cirrhosis, and effective drugs are needed. In this study, we explored the protective effect of bergenin on liver fibrosis induced by carbon tetrachloride and bile duct ligation. A variety of molecular biological methods (qRT-PCR, western blotting, and immunohistochemistry) were employed to confirm the increased degree of hepatocyte injury and ECM formation in the disease model, consistent with autophagy and activation of the TGF-β pathway. Bergenin activated PPAR-γ and inhibited TGF-β and autophagy and decreased liver fibrosis by inhibiting hepatocyte necrosis and ECM formation in a dose-dependent manner. The results suggest that bergenin may be a promising drug candidate for the treatment of liver fibrosis.Keywords
Funding Information
- Science and Technology Commission of Putuo District (ptkwws201901, CFHPC2019031)
- Chinese Foundation for Hepatitis Prevention and Control (ptkwws201901, CFHPC2019031)
This publication has 36 references indexed in Scilit:
- Isorhamnetin: A hepatoprotective flavonoid inhibits apoptosis and autophagy via P38/PPAR-α pathway in miceBiomedicine & Pharmacotherapy, 2018
- Alleviation of hepatic fibrosis and autophagy via inhibition of transforming growth factor‐β1/Smads pathway through shikoninJournal of Gastroenterology and Hepatology, 2018
- Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathwaysScientific Reports, 2017
- Pharmacological modulation of autophagy: therapeutic potential and persisting obstaclesNature Reviews Drug Discovery, 2017
- Hepatostat: Liver regeneration and normal liver tissue maintenanceHepatology, 2017
- Emerging Mechanisms in Initiating and Terminating AutophagyTrends in Biochemical Sciences, 2017
- Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalingsClinical and Experimental Medicine, 2016
- Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagyDrug Design, Development and Therapy, 2016
- A role for autophagy during hepatic stellate cell activationJournal of Hepatology, 2011
- Peroxisome Proliferator-activated Receptor γ Inhibits Transforming Growth Factor β-induced Connective Tissue Growth Factor Expression in Human Aortic Smooth Muscle Cells by Interfering with Smad3Journal of Biological Chemistry, 2001